Adjuvant chemotherapy in stage-II breast cancer: An overview of the NSABP clinical trials
- 1 March 1983
- journal article
- clinical trial
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 3 (1) , S19-S26
- https://doi.org/10.1007/bf01855123
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Combination chemotherapy (CMFVP) versus L-phenylalanine mustard (L-PAM) for operable breast cancer with positive axillary nodes. A southwest oncology group studyCancer, 1982
- Treatment of Primary Breast Cancer with Chemotherapy and TamoxifenNew England Journal of Medicine, 1981
- ACUTE TOXICITY DURING ADJUVANT CHEMOTHERAPY FOR BREAST-CANCER - THE NATIONAL-SURGICAL-ADJUVANT-BREAST-AND-BOWEL-PROJECT (NSABP) EXPERIENCE FROM 1717 PATIENTS RECEIVING SINGLE AND MULTIPLE AGENTS1981
- Dose-Response Effect of Adjuvant Chemotherapy in Breast CancerNew England Journal of Medicine, 1981
- Laboratory and clinical research in breast cancer--a personal adventure: the David A. Karnofsky memorial lecture.1980
- The contribution of recent nsabp clinical trials of primary breast cancer therapy to an understanding of tumor biology—an overview of findingsCancer, 1980
- Ten year follow-up results of patients with carcinoma of the breast in a co-operative clinical trial evaluating surgical adjuvant chemotherapy.1975
- Combination cytotoxic chemotherapy in advanced disseminated breast carcinoma.1966
- Response of advanced breast carcinoma to the combination of the antimetabolite, Methotrexate, and the alkylating agent, thio-TEPA.1963